Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02831933
Title Trial of Stereotactic Body Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma (ENSIGN)
Acronym ENSIGN
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eric Bernicker, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.